Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pazdur

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Investigational New Drugs|January 1, 1994
Phase II trial of intravenous melphalan in advanced colorectal carcinomaD F Moore, R Pazdur, J L Abbruzzese
Investigational New Drugs|June 1, 1988
PCNU: phase II evaluation in advanced colorectal carcinomaR Pazdur, M K Samson, L H Baker
American Journal of Clinical Oncology|April 1, 1987
CBDCA: phase II evaluation in advanced colorectal carcinomaR Pazdur, M K Samson, L H Baker
Clinical Pharmacology and Therapeutics|January 12, 2017
Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing ScienceG M Blumenthal, K B Goldberg, R Pazdur
American Journal of Clinical Oncology|June 1, 1987
Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinomaR Pazdur, M K Samson, L H Baker
Investigational New Drugs|December 16, 1998
Phase II study of prolonged infusion of Taxol in patients with metastatic colorectal carcinomaJ A Ajani, R Pazdur, P Dumas, et al.
Cancer Investigation|April 29, 1998
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day scheduleR Pazdur, Y Lassere, E Diaz-Canton, et al.
Cancer|July 1, 1987
Prospective evaluation of adrenal insufficiency in patients with adrenal metastasisB G Redman, R Pazdur, A P Zingas, et al.
Seminars in Oncology|October 1, 1994
A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary reportD Kelsen, J Ajani, D Ilson, et al.
Anti-Cancer Drugs|January 7, 1999
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancerP M Hoff, R Pazdur, S E Benner, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Investigational New Drugs|January 1, 1994
Phase II trial of intravenous melphalan in advanced colorectal carcinomaD F Moore, R Pazdur, J L Abbruzzese
Investigational New Drugs|June 1, 1988
PCNU: phase II evaluation in advanced colorectal carcinomaR Pazdur, M K Samson, L H Baker
American Journal of Clinical Oncology|April 1, 1987
CBDCA: phase II evaluation in advanced colorectal carcinomaR Pazdur, M K Samson, L H Baker
Clinical Pharmacology and Therapeutics|January 12, 2017
Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing ScienceG M Blumenthal, K B Goldberg, R Pazdur
American Journal of Clinical Oncology|June 1, 1987
Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinomaR Pazdur, M K Samson, L H Baker
Investigational New Drugs|December 16, 1998
Phase II study of prolonged infusion of Taxol in patients with metastatic colorectal carcinomaJ A Ajani, R Pazdur, P Dumas, et al.
Cancer Investigation|April 29, 1998
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day scheduleR Pazdur, Y Lassere, E Diaz-Canton, et al.
Cancer|July 1, 1987
Prospective evaluation of adrenal insufficiency in patients with adrenal metastasisB G Redman, R Pazdur, A P Zingas, et al.
Seminars in Oncology|October 1, 1994
A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary reportD Kelsen, J Ajani, D Ilson, et al.
Anti-Cancer Drugs|January 7, 1999
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancerP M Hoff, R Pazdur, S E Benner, et al.
Pageof 16